These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6792389)

  • 21. Naftifine solution (1%) in the treatment of pityriasis versicolor in Zambia.
    Hira SK; Abraham MS; Mwinga A; Kamanga J; Schmidt C
    Mykosen; 1986 Aug; 29(8):378-81. PubMed ID: 3531847
    [No Abstract]   [Full Text] [Related]  

  • 22. [Naftifin in foot mycoses. Double-blind therapeutic comparison with clotrimazole].
    Haas PJ; Tronnier H; Weidinger G
    Mykosen; 1985 Jan; 28(1):33-40. PubMed ID: 3883160
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antimycotic effect of naftifin in tinea pedis. Comparative double-blind study with bifonazole].
    Bojanovsky A; Haas P
    Fortschr Med; 1985 Jul; 103(25):677-9. PubMed ID: 3897005
    [No Abstract]   [Full Text] [Related]  

  • 24. New and prospective developments in antifungal drugs.
    Cauwenbergh G
    Acta Derm Venereol Suppl (Stockh); 1986; 121():147-53. PubMed ID: 3012922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Naftifin--laboratory and clinical experience with a new antimycotic from the allylamine group].
    Otcenásek M; Péc J; Moravcík P
    Cas Lek Cesk; 1993 Jun; 132(13):406-9. PubMed ID: 8370053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis.
    Del Rosso JQ; Kircik LH
    J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naftifine cream in the treatment of cutaneous candidiasis.
    Zaias N; Astorga E; Cordero CN; Day RM; de Espinoza ZD; DeGryse R; Rojas RF; Sefton J
    Cutis; 1988 Sep; 42(3):238-40. PubMed ID: 3048914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naftifine: a review.
    Gupta AK; Ryder JE; Cooper EA
    J Cutan Med Surg; 2008; 12(2):51-8. PubMed ID: 18346400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group.
    J Am Podiatr Med Assoc; 1990 Jun; 80(6):314-8. PubMed ID: 2189989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amorolfine, a breakthrough in topical antimycotic therapy. Introduction.
    Hay RJ
    Dermatology; 1992; 184 Suppl 1():1-2. PubMed ID: 1550965
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of dermatophytoses II: Newer topical antifungal drugs.
    Stiller MJ; Shupack JL; Rosenthal SA
    Int J Dermatol; 1993 Sep; 32(9):638-41. PubMed ID: 8407088
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B
    J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naftifine for fungal skin infections.
    Med Lett Drugs Ther; 1988 Oct; 30(777):98-9. PubMed ID: 3050410
    [No Abstract]   [Full Text] [Related]  

  • 34. An open-label pilot study of naftifine 1% gel in the treatment of seborrheic dermatitis of the scalp.
    Gold MH; Bridges T; Avakian EV; Plaum S; Fleischer AB; Hardas B
    J Drugs Dermatol; 2012 Apr; 11(4):514-8. PubMed ID: 22453590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An open-label study of naftifine hydrochloride 1% gel in the treatment of tinea versicolor.
    Gold MH; Bridges T; Avakian E; Plaum S; Pappert EJ; Fleischer AB; Hardas B
    Skinmed; 2011; 9(5):283-6. PubMed ID: 22165042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea Pedis.
    Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Jul; 14(7):686-91. PubMed ID: 26151784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naftifine, a topical allylamine.
    Marks S; Cantrell W; Varma R; Elewski B
    J Drugs Dermatol; 2010 Jul; 9(7):750. PubMed ID: 20677526
    [No Abstract]   [Full Text] [Related]  

  • 38. Naftifine gel in the treatment of tinea pedis: two double-blind, multicenter studies. Naftifine Gel Study Group.
    Cutis; 1991 Jul; 48(1):85-8. PubMed ID: 1868748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis.
    Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB
    J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allergic contact dermatitis from naftifine in a child without cross-reaction to terbinafine.
    Goday JJ; González-Güemes M; Yanguas I; Ilardia R; Soloeta R
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):72-3. PubMed ID: 9731972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.